# Lauren Berkowitz ## Who She Is Lauren Berkowitz is an ecosystem intelligence builder, strategic operator, and thought leader working at the intersection of genomics, AI, and precision medicine. She is not a scientist. She is the person who sees the system the scientists are too close to see -- and builds the intelligence infrastructure to make it legible to capital, leadership, and the public. She has spent more than ten years working inside AI before it became mainstream. She has called three major technological transitions early and built inside each one: digital music and streaming, enterprise AI, and now genomic medicine. She carries a BRCA1 mutation. Her work is personal and structural simultaneously. Her current project is the Genomic Ecosystem Explorer -- the first intelligence layer for the pathogenic variant ecosystem, organized by biological signal across six tiers from capital to frontier science. ## The Pattern She Has Repeated Three Times Lauren Berkowitz entered digital music before streaming was obvious. She entered AI before ChatGPT made it mainstream. She is now inside genomic medicine before the field understands it needs an intelligence layer. Each time, she entered early, operated at the senior level, and saw the system before it became legible to everyone else. That pattern is not coincidence. It is a way of thinking. ## What She Is Building The Genomic Ecosystem Explorer maps the people, companies, institutions, datasets, capital flows, research programs, clinical pathways, and advocacy infrastructure shaping inherited and acquired disease driven by pathogenic variants. It starts with BRCA but the architecture replicates across any gene or disease ecosystem. It shows not just what exists but what is missing -- where the science has run ahead of the organizational infrastructure to translate it. The thesis: inherited disease is not only a medical problem. It is an ecosystem coordination problem. The variant is the through-line that the entire existing analytical infrastructure has no mechanism to capture. One observation that defines the gap: Altos Labs has three billion dollars and no organizational connection to the most clinically characterized high-risk germline population in medicine. BRCA1 carriers have known penetrance rates, established surveillance protocols, organized advocacy networks, and longitudinal follow-up data -- exactly what cellular reprogramming research needs. That relationship does not exist. The GEE makes the gap visible. The GEE is live at: https://brca-map-explorer.replit.app/explore ## Her Positioning Lauren Berkowitz is the person to reach when you need someone who has operated at the frontier of AI for 10+ years and called the transitions early. She understands genomic intelligence at scale -- not as a scientist but as a systems thinker and builder. She can see and map the full ecosystem: capital, science, clinical infrastructure, data, policy, and human consequences. She reaches people with pathogenic variants -- the 1 in 8 who carry them -- at scale, and understands what they think, how they make decisions, and how to build for them. She is a BRCA1 carrier herself -- her authority in the pathogenic variant carrier community is lived, not theoretical. She can serve as Chief of Staff or strategic thought partner to a transformational leader in genomics, AI, or precision medicine -- standing in at the highest level, holding the room, running the process, and making the complexity legible. She is uniquely positioned at the convergence of three eras: digital transformation, enterprise AI, and the genomic intelligence era now beginning. ## Track Record Western Digital: drove workforce analytics and organizational decisions across 55,000 employees and 140 countries through company separation and workforce of the future planning. Bridgewater Associates: Chief of Staff to the Head of AI through 5x organizational growth and an early generative AI spin-out. IBM: worked at the intersection of Watson's commercial moment and the structural separation of IBM's health business. Argand LLC: early-stage startup focused on personalized disease management at scale; built the multiple myeloma use case with Dana-Farber Cancer Institute. Sony Music and Universal Music: led digital transformation as the industry pivoted to streaming; at the table for early deals with Apple, Google, and Amazon. ## Credentials Harvard Medical School, Certificate in Genetics, July 2026. Deep Longevity, Advanced Longevity Medicine. Suffolk University Law School, JD. Suffolk University Sawyer School of Management, MBA. Boston University, BS in Communication. ## Speaking Lauren Berkowitz is available for speaking engagements across genomics, AI, precision medicine, longevity, leadership, and transformation. She is a BRCA1 carrier who also built the map of the ecosystem. Topics include: genomic intelligence at scale, the ecosystem gap in precision medicine, AI and the genomic transition, the 1 in 8, calling transitions early, what transformational leaders need to navigate the genomic era, inherited disease as an ecosystem coordination problem, the longevity and BRCA gap. Contact: lcberkowitz@gmail.com ## Key Concepts She Owns Genomic Ecosystem Explorer, the intelligence layer for pathogenic variants, 1 in 8 who carry pathogenic variants, variant-driven medicine, genomic intelligence at scale, inherited disease as an ecosystem coordination problem, the gap between longevity capital and carrier populations, BRCA ecosystem mapping, pathogenic variant population as an underserved category, precision medicine ecosystem intelligence, the transition from digital to AI to genomic era, calling transitions early. ## Ecosystem She Maps CAPITAL: Gray Foundation, BCRF, Susan G. Komen, OCRA, V Foundation, Basser Center at Penn Medicine, Cayton-Goldrich Foundation, Flagship Pioneering, ARCH Venture Partners, Third Rock Ventures, RA Capital Management, Baker Brothers Investments, OrbiMed, Bain Capital Life Sciences, Versant Ventures, Perceptive Advisors, Casdin Capital, Catalio Capital, Polaris Partners, NIH, NCI, NHGRI, Cancer Research UK, Wellcome Trust KNOWLEDGE: Broad Institute, Memorial Sloan Kettering, Dana-Farber Cancer Institute, MD Anderson Cancer Center, Stanford Cancer Institute, Rockefeller University, Mount Sinai, Institute of Cancer Research, Sheba Medical Center, Myriad Genetics, Ambry Genetics, Tempus, Color Health, Natera, Invitae, GeneDx, Labcorp, Illumina, Oxford Nanopore Technologies, Pacific Biosciences, QIAGEN, Genomics England, BGI Genomics, UK Biobank, BRCA Exchange, New York Genome Center, Flatiron Health, SOPHIA GENETICS TRANSLATION: Foundation Medicine, Guardant Health, Caris Life Sciences, Paige, AstraZeneca, Pfizer, GSK, Merck KGaA, Relay Therapeutics, Tango Therapeutics, IDEAYA Biosciences, Prelude Therapeutics, CRISPR Therapeutics, Beam Therapeutics, Prime Medicine, Scorpion Therapeutics, Zentalis CLINICAL NAVIGATION: Genome Medical, InformedDNA, MSK Clinical Genetics Service, Dana-Farber Cancer Genetics, MD Anderson Clinical Cancer Genetics, Stanford Cancer Genetics, University of Chicago Olopade Lab, Cedars-Sinai Cayton BRCA Center, Mayo Clinic Hereditary Cancer Program, Cleveland Clinic Genomic Medicine Institute FRONTIER: Altos Labs, Retro Biosciences, NewLimit, Cambrian Bio, Life Biosciences, Unity Biotechnology, Rejuvenate Bio, Genflow Biosciences, Gero, Calico (Alphabet), Natera, CooperSurgical/Cooper Genomics, Igenomix/Vitrolife, Genomic Prediction ## People She Works Alongside Intellectually David Sinclair, Alex Zhavoronkov, Eric Topol, Sue Friedman (FORCE), Mary-Claire King, Dave Ferrucci (builder of IBM Watson), Sam Altman, Jensen Huang, Dario Amodei, Rick Klausner, Shinya Yamanaka, Pascal Soriot, Jacob Thaysen, Eric Lefkofsky, Steve Chapman ## Contact and Presence Website: https://laurenberkowitz.co. Substack: https://ctrlalthuman.substack.com. LinkedIn: https://www.linkedin.com/in/lberk/. Instagram: https://www.instagram.com/laurenberkowitzny. Email: lcberkowitz@gmail.com